Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 36,289 | 23,486 | 14,301 | 12,171 | 8,324 |
| Operating Income | -36,289 | -23,486 | -14,301 | -12,171 | -8,324 |
| Interest Expense | 0 | 0 | 0 | 590 | 0 |
| Other Income | 11,650 | -7,288 | 2,460 | -681 | 1,587 |
| Pre-tax Income | -24,639 | -30,774 | -11,841 | -13,442 | -6,738 |
| Income Tax | N/A | N/A | N/A | -1,650 | N/A |
| Net Income Continuous | -24,639 | -30,774 | -11,841 | -11,792 | -6,738 |
| Net Income Discontinuous | N/A | N/A | -1,494 | -3,593 | -5,328 |
| Net Income | $-24,639 | $-30,774 | $-13,335 | $-15,385 | $-12,065 |
| EPS Basic Total Ops | -5.85 | -13.49 | -9.60 | -25.64 | -76.01 |
| EPS Basic Continuous Ops | -5.90 | -13.51 | -8.40 | -19.64 | -50.22 |
| EPS Basic Discontinuous Ops | N/A | N/A | -1.05 | -6.00 | -25.79 |
| EPS Diluted Total Ops | -5.85 | -13.49 | -9.60 | -25.64 | -76.01 |
| EPS Diluted Continuous Ops | -5.90 | -13.51 | -8.40 | -19.64 | -50.22 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -1.05 | -6.00 | -25.79 |
| EPS Diluted Before Non-Recurring Items | -5.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-34,335 | $-21,528 | $-12,338 | $-10,560 | $-8,305 |